Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007
- PMID: 22348163
- PMCID: PMC3279342
- DOI: 10.1371/journal.pntd.0001508
Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007
Abstract
Background: Chagas' disease is an important neglected public health problem in many Latin American countries, but population-based epidemiological data are scarce. Here we present a nationwide analysis on Chagas-associated mortality, and risk factors for death from this disease.
Methodology/principal findings: We analyzed all death certificates of individuals who died between 1999 and 2007 in Brazil, based on the nationwide Mortality Information System (a total of 243 data sets with about 9 million entries). Chagas' disease was mentioned in 53,930 (0.6%) of death certificates, with 44,537 (82.6%) as an underlying cause and 9,387 (17.4%) as an associated cause of death. Acute Chagas' disease was responsible for 2.8% of deaths. The mean standardized mortality rate was 3.36/100.000 inhabitants/year. Nationwide standardized mortality rates reduced gradually, from 3.78 (1999) to 2.78 (2007) deaths/year per 100,000 inhabitants (-26.4%). Standardized mortality rates were highest in the Central-West region, ranging from 15.23 in 1999 to 9.46 in 2007 (-37.9%), with a significant negative linear trend (p = 0.001; R(2) = 82%). Proportional mortality considering multiple causes of death was 0.60%. The Central-West showed highest proportional mortality among regions (2.17%), with a significant linear negative trend, from 2.28% to 1.90% (-19.5%; p = 0.001; R(2) = 84%). There was a significant increase in the Northeast of 38.5% (p = 0.006; R(2) = 82%). Bivariable analysis on risk factors for death from Chagas' disease showed highest relative risks (RR) in older age groups (RR: 10.03; 95% CI: 9.40-10.70; p<0.001) and those residing in the Central-West region (RR: 15.01; 95% CI: 3.90-16.22; p<0.001). In logistic regression analysis, age ≥30 years (adjusted OR: 10.81; 95% CI: 10.03-10.65; p<0.001) and residence in one of the three high risk states Minas Gerais, Goiás or the Federal District (adjusted OR: 5.12; 95% CI: 5.03-5.22, p<0.001) maintained important independent risk factors for death by Chagas' disease.
Conclusions/significance: This is the first nationwide population-based study on Chagas mortality in Brazil, considering multiple causes of death. Despite the decline of mortality associated with Chagas' disease in Brazil, the disease remains a serious public health problem with marked regional differences.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Levels and trends in Chagas disease-related mortality in Brazil, 2000-2019.Acta Trop. 2021 Aug;220:105948. doi: 10.1016/j.actatropica.2021.105948. Epub 2021 May 7. Acta Trop. 2021. PMID: 33971159
-
Mortality Trends for Neglected Tropical Diseases in the State of Sergipe, Brazil, 1980-2013.Infect Dis Poverty. 2017 Feb 8;6(1):20. doi: 10.1186/s40249-016-0232-8. Infect Dis Poverty. 2017. PMID: 28173858 Free PMC article.
-
Mortality of Chagas' disease in Brazil: spatial patterns and definition of high-risk areas.Trop Med Int Health. 2012 Sep;17(9):1066-75. doi: 10.1111/j.1365-3156.2012.03043.x. Epub 2012 Jul 19. Trop Med Int Health. 2012. PMID: 22809055
-
Reprint of "Neurocysticercosis-related mortality in Brazil, 2000-2011: Epidemiology of a neglected neurologic cause of death".Acta Trop. 2017 Jan;165:170-178. doi: 10.1016/j.actatropica.2016.11.009. Epub 2016 Nov 23. Acta Trop. 2017. PMID: 27887696 Review.
-
[Pragmatic data and observations related to the epidemiology of Chagas disease].Bol Chil Parasitol. 1989 Jul-Dec;44(3-4):66-86. Bol Chil Parasitol. 1989. PMID: 2518649 Review. Spanish.
Cited by
-
The detection of Trypanosoma cruzi by nested-PCR in elderly patients: relationship to the clinical and epidemiological profile.Pathog Glob Health. 2016 Sep;110(6):228-232. doi: 10.1080/20477724.2016.1232850. Epub 2016 Sep 26. Pathog Glob Health. 2016. PMID: 27666187 Free PMC article.
-
Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.PLoS Negl Trop Dis. 2016 Apr 15;10(4):e0004584. doi: 10.1371/journal.pntd.0004584. eCollection 2016 Apr. PLoS Negl Trop Dis. 2016. PMID: 27082760 Free PMC article.
-
Chagas disease mortality in Brazil: A Bayesian analysis of age-period-cohort effects and forecasts for two decades.PLoS Negl Trop Dis. 2018 Sep 28;12(9):e0006798. doi: 10.1371/journal.pntd.0006798. eCollection 2018 Sep. PLoS Negl Trop Dis. 2018. PMID: 30265661 Free PMC article.
-
Identification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arrays.PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2524. doi: 10.1371/journal.pntd.0002524. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24205430 Free PMC article.
-
2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas' disease.Bioorg Med Chem Lett. 2018 Oct 1;28(18):3025-3030. doi: 10.1016/j.bmcl.2018.08.005. Epub 2018 Aug 3. Bioorg Med Chem Lett. 2018. PMID: 30104093 Free PMC article.
References
-
- Coura JR. Chagas' disease: what is known and what's needed – A background article. Mem Inst Oswaldo Cruz. 2007;102:113–122. - PubMed
-
- Ramos AN, Jr, Heukelbach J. Chagas' disease (BMJ Point of Care - Monograph) London: British Medical Journal Group; 2010.
-
- Schmunis GA, Yadon ZE. Chagas' disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21. - PubMed
-
- Kirchhoff LV. Epidemiology of American trypanosomiasis (Chagas' disease). Adv Parasitol. 2011;75:1–18. - PubMed
-
- Guariento ME, Carrijo CM, Almeida EA, Magna LA. Perfil clínico de idosos portadores de doença de Chagas atendidos em serviço de referência. Rev Bras Clin Med. 2011;9:20–24.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical